Spero Therapeutics (SPRO) Other Gross PP&E Adjustments (2016 - 2025)
Spero Therapeutics (SPRO) has disclosed Other Gross PP&E Adjustments for 10 consecutive years, with -$2.3 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Other Gross PP&E Adjustments rose 42.62% year-over-year to -$2.3 million, compared with a TTM value of -$2.3 million through Sep 2025, up 42.62%, and an annual FY2024 reading of -$1.7 million, down 36.2% over the prior year.
- Other Gross PP&E Adjustments was -$2.3 million for Q3 2025 at Spero Therapeutics, up from -$3.5 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$1.2 million in Q4 2023 and bottomed at -$8.5 million in Q1 2021.
- Average Other Gross PP&E Adjustments over 5 years is -$5.0 million, with a median of -$4.8 million recorded in 2024.
- The sharpest move saw Other Gross PP&E Adjustments plummeted 55.8% in 2021, then skyrocketed 43.5% in 2023.
- Year by year, Other Gross PP&E Adjustments stood at -$3.5 million in 2021, then surged by 37.73% to -$2.2 million in 2022, then skyrocketed by 43.5% to -$1.2 million in 2023, then crashed by 36.2% to -$1.7 million in 2024, then tumbled by 35.56% to -$2.3 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for SPRO at -$2.3 million in Q3 2025, -$3.5 million in Q2 2025, and -$3.7 million in Q1 2025.